SPECIFICITY OF HUMAN AUTOANTIBODIES TO PROTEOGLYCANS
SPECIFICITY OF HUMAN AUTOANTIBODIES TO PROTEOGLYCANS
批准号:
3138135
负责人:
Howard M. Fillit
金额:
$17.51万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-01-01 至 1992-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): Proteoheparan sulfate
(PHS) proteoglycan (PG) on the endothelial cell surface and vascular
basement membrane plays an important role in the vascular permeability
barrier. Heparin sulfate (HS) contributes the majority of anionic charges
to the vascular charge barrier. PHS protein core plays a structural role
in the vascular barrier by its multiple binding sites for laminin, type IV
collagen and other molecules. Animal models have demonstrated that
cationic molecules which bind HS, and antibodies to PHS protein core, cause
vascular injury. The investigators and others have demonstrated that sera
from patients with autoimmune vascular disease have autoantibodies to PHS.
The investigators hypothesis is that autoimmunity to PHS causes vascular
injury in human autoimmune disease. The investigators propose that both
humoral and cellular autoimmunity to PHS components (HS and protein core
peptides) cause vascular injury by classic mechanisms, including the
activation of complement, initiation of the inflammatory cascade, and
endothelial cell cytotoxicity. The investigators also propose hypotheses
regarding the immunochemistry of proteoglycan autoimmunity. First, while
autoantibodies which broadly cross-react with anionic molecules have been
described, the investigators have demonstrated autoantibodies to
glycosaminoglycans (GAGS) which are highly specific. The investigators
propose that these highly specific autoantibodies have high affinity for HS
and are more efficient than broadly cross-reactive, low affinity
autoantibodies in activating complement, and initiating inflammation.
Thus, the investigators propose that antibody affinity determines the
pathologic significance of autoimmunity to anionic molecules such as the
GAGS. Secondly, PGs play a role in organ-specificity. The
organ-specificity of proteoglycans is determined primarily by the nature of
the protein core. The investigators propose that specific PHS protein core
epitopes are immunologic targets in organ specific autoimmune disease.
Finally, the investigators propose that cell-mediated immunity causes
vascular injury via T-cell recognition of PHS sites which may differ from
PHS epitopes recognized by autoantibody.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2019-2021 Drug Discovery for Neurodegeneration Conferences
-
批准号:10180809
-
项目类别:
-
资助金额:$7.49万
-
财政年份:2019
-
负责人:Howard M. Fillit
-
依托单位:
2016-2018 Drug Discovery for Neurodegeneration Conferences
-
批准号:9051961
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2015
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:7332301
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:7806086
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:8256947
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:7614073
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:8650510
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:8458836
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:7806181
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
Drug Discovery for Neurodegeneration
-
批准号:8061791
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2007
-
负责人:Howard M. Fillit
-
依托单位:
SPECIFICITY OF HUMAN AUTOANTIBODIES TO PROTEOGLYCANS
-
批准号:3138139
-
项目类别:
-
资助金额:$18.15万
-
财政年份:1990
-
负责人:Howard M. Fillit
-
依托单位:
SPECIFICITY OF HUMAN AUTOANTIBODIES TO PROTEOGLYCANS
-
批准号:3138138
-
项目类别:
-
资助金额:$17.46万
-
财政年份:1990
-
负责人:Howard M. Fillit
-
依托单位:
海外基金